Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Therapeutic Antibodies and Altana enter alliance for emergency medicine products

Oct. 17, 1997

Orphan Medical licenses out European rights to Antizol

Sep. 23, 1997

Sano's combination patch shows promise for smoking cessation

Sep. 12, 1997

Guilford receives government contract for cocaine addiction research

Aug. 11, 1997

Algos and NIDA enter into collaboration for heroin addiction treatment

Aug. 7, 1997

Nicotine Inhaler launched in The Netherlands

July 24, 1997

Novartis prepares orally active iron chelators

July 23, 1997

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...